Continuing Education Activities
Here at JADPRO CE, you can find a valuable array of certified educational opportunities: it’s the place to get your credits and update your learning in oncology. We provide advanced practitioners like you with a wide range of continuing education, covering the most current topics in several formats so you can choose the way you want to learn. You'll find that our CE offerings are easy to navigate. You can sort by topic and/or format, or simply browse the site and get started!
Approaches for Optimal Molecular Testing, Treatment, and Management of NSCLC and Accompanying Driver Mutations
Posted: October 18, 2021 / Expires: December 31, 2022
Estimated time to complete: 1.25 hours
CLL/SLL: Managing Adverse Events Associated with BTK Inhibitor Therapy
Posted: October 18, 2021 / Expires: December 31, 2022
Estimated time to complete: 1.25 hours
Navigating the Expanding Treatment Landscape in Metastatic Urothelial Cancer: Novel Targeted Therapies
Posted: October 18, 2021 / Expires: December 31, 2022
Estimated time to complete: 1.25 hours
Navigating the Evolving Treatment Landscape in Prostate Cancer: A Focus on Novel Anti-androgen Therapy
Posted: October 18, 2021 / Expires: December 31, 2022
Estimated time to complete: 1.25 hours
Metastatic HER2-Positive Breast Cancer: Newer and Emerging Treatment Considerations and Personalized Therapies
Posted: October 18, 2021 / Expires: December 31, 2022
Estimated time to complete: 1.25 hours
CDK4/6 Inhibitors: Paving the Way for HR-Positive, HER2-Negative Early Breast Cancer
This activity will review the latest emerging evidence for CDK4/6 inhibitors in the adjuvant setting for early breast cancer. Interprofessional perspectives and recommendations for improving adherence and side effect management will be featured.
Posted: November 17, 2021 / Expires: November 16, 2022
Estimated time to complete: 0.5 hour
Hemophilia A: Strategies for Improving Long-Term Holistic Management, Adherence, and Quality of Life
This educational activity reviews currently approved prophylaxis therapy in hemophilia A, the benefits of prophylaxis and adherence, and patient quality-of-life factors. Interprofessional perspectives from an expert faculty panel are featured.
Posted: May 25, 2022 / Expires: May 24, 2023
Estimated time to complete: 0.5 hour
Multiple Myeloma and Plasma Cell Disorders: Update on Diagnosis, Prognosis, Treatment, and Supportive Care
Developed by members of the International Myeloma Foundation (IMF) Nurse Leadership Board, this supplement contains case studies demonstrating clinical decision-making and reflecting the latest updates in managing multiple myeloma and plasma cell disorders.
Posted: June 30, 2022 / Expires: July 1, 2023
Estimated time to complete: 2.5 hours